Business
AstraZeneca unveils antibody treatment, preventative shot for those who can’t get vaccinated – The Sydney Morning Herald
The company said its drug offered hope to those who can’t receive COVID-19 vaccines, such as cancer patients, organ transplant…
The full results will be submitted for publication in a peer-reviewed medical journal.
Pascal Soriot, CEO of AstraZeneca, said the data showed the drug offered protection for six months and could last for 12 months, but the company needed a further six…
Continue Reading
-
Noosa News15 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business16 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News19 hours agoNo conviction recorded for teen behind attack on Peter Dutton’s office
-
Noosa News19 hours ago‘They’re not taking the concerns of women seriously’